Autoimmune Disease Diagnostics Market is Projected to Expand at a Steady CAGR Over the Forecast - 2031 |Abbott Laboratories, Bio-rad Laboratories, F. Hoffmann-la Roche, Thermo Fisher Scientific.

The global autoimmune disease diagnostics market was valued at USD 1.3 billion in 2021 and it is anticipated to grow up to USD 3.1 billion by 2031, at a CAGR of 9.2% during the forecast period.

Market Trends and Drivers

Substantial surge in the number of patients affected with autoimmune diseases is amongst the major factors propelling the market growth in the foreseeable future. Type 1 diabetes, rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease among others are some of the most common diseases that require autoimmune diagnostics and treatment. Type 1 diabetes is a chronic ailment that is generally caused when the immune system attacks and destroys insulin-producing cells in the pancreas. This results in high blood sugar level and if left untreated may lead to multiple organ failure including heart, kidneys, nerves, etc.

To Remain 'Ahead' Of Your Competitors, Request for A Sample - https://www.globalinsightservices.com/request-sample/GIS24309

For instance, according to the reports published by the International Diabetes Federation, in 2021, over 1.2 million children and adolescents below the age of 19 years are infected with type 1 diabetes and the numbers are growing at a steady pace. Moreover, according to the America Diabetes Association, in 2019 over 1.9 million Americans were suffering from Type 1 diabetes. The increasing prevalence of such disease promotes significant health consequences and co-morbidities that also results in substantial mortality.

Major Players in the Global Autoimmune Disease Diagnostics Market

The key players in the autoimmune disease diagnostics market are Abbott Laboratories, Bio-rad Laboratories, F. Hoffmann-la Roche, Thermo Fisher Scientific, EUROIMMUN Medizinische Labordiagnostika AG (Perkin Elmer), Siemens Healthineers Inc, Quest Diagnostics, SQI Diagnostics Inc., Trinity Biotech Plc., and Hemagen Diagnostics, among others.

Report Overview- https://www.globalinsightservices.com/reports/autoimmune-disease-diagnostics-market/

 COVID-19 Impact

The COVID-19 pandemic emerged as an unprecedented global pandemic, affecting the healthcare sector by disrupting the global supply chain. During the initial phase of the outbreak, in the first half of 2020, the pandemic hampered the growth of the autoimmune disease diagnostics market. National emergencies and lockdowns were imposed in numerous countries to prevent the spread of the COVID-19 virus. The lockdown and travel restrictions had a negative influence on health systems.

The coronavirus pandemic had an impact on the autoimmune disease diagnostics business by restricting product uptake and associated procedures. It had an impact on consumer and manufacturers by significantly reducing and delaying the number of non-emergency surgical procedures conducted and patients assessed for eligibility of autoimmune disease diagnostics. According to the reports of the National Center of Biotechnology Information (NCBI), in 2021, the patients suffering from the rheumatoid arthritis (RA) had a high risk of developing COVID-19. This led in more stringent operational procedures that elevated the product demand. The combined efforts of certain regulatory authorities and market players contributed to reducing the impact of the pandemic. Furthermore, autoimmune disease diagnostics reached pre-pandemic diagnostic volume in 2021. Thus, the COVID-19 pandemic delayed industry growth marginally; however, restoring surgical volume would help market expansion in the near future.

Get A Customized Scope to Match Your Need Ask an Expert- https://www.globalinsightservices.com/request-customization/GIS24309

Global Autoimmune Disease Diagnostics Market Segmentation

By Disease Type

Systemic Autoimmune Disease
Rheumatoid Arthritis
Systemic Lupus Erythematosus (SLE)
Psoriasis
Multiple Sclerosis
Others
Localized Autoimmune Disease
Inflammatory Bowel Disease
Type 1 Diabetes
Thyroid
Others

By Test Type

Antinuclear Antibody Tests
Autoantibody Tests
C-reactive Protein (CRP)
Complete Blood Count (CBC)
Urinalysis
Others

By End-user

Hospitals
Diagnostic Centres
Others

For In-Depth Competitive Analysis, Purchase this Report- https://www.globalinsightservices.com/inquiry-before-buying/GIS24309

With Global Insight Services, you receive:

10-year forecast to help you make strategic decisions
In-depth segmentation which can be customized as per your requirements
Free consultation with lead analyst of the report
Excel data pack included with all report purchases
Robust and transparent research methodology

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/

This release was published on openPR.